During the past 3 years, the average EBITDA Per Share Growth Rate was 35.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 73.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 58.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioRestorative Therapies was 85.10% per year. The lowest was -37.70% per year. And the median was 24.80% per year.
Competitive Comparison of BioRestorative Therapies's 5-Year EBITDA Growth Rate
For the Biotechnology subindustry, BioRestorative Therapies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioRestorative Therapies's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where BioRestorative Therapies's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
BioRestorative Therapies 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of BioRestorative Therapies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BRTX has been successfully added to your